CONSHOHOCKEN, Pa., April 1, 2026 /PRNewswire/ — Tiger BioSciences today announced the launch of carePAC™, a line of pre-configured wound care convenience kits designed to simplify dressing changes and improve access to essential wound care supplies for patients managing wounds at home.

carePAC™ kits contain carefully selected wound care components packaged together to support consistent, patient-friendly dressing changes. By providing the necessary materials in a single, easy-to-use format, carePAC™ aims to reduce complexity for patients and caregivers while supporting adherence to provider-directed wound care protocols.

The launch represents a continued expansion of Tiger BioSciences’ commitment to improving patient access to high-quality wound care solutions both in the clinic and at home.

“Wound care does not stop when a patient leaves the clinic,” said Garrett Grinsfelder, President of Tiger Wound Care. “With carePAC™, we are helping bridge the gap between the clinical setting and the home by delivering convenient, pre-configured kits that simplify the dressing change process and support better continuity of care.”

Each carePAC™ kit is designed to provide the supplies needed for routine dressing changes in a sealed, organized pouch format. The kits are intended to support both patients and caregivers by reducing the need to source multiple individual products while promoting consistent wound care practices.

“carePAC™ was developed with both providers and patients in mind,” said Oliver Burckhardt, Co-CEO of Tiger BioSciences. “By pre-configuring the components required for dressing changes, we can help streamline care delivery, reduce patient confusion, and ultimately support improved wound management outcomes.”

About Tiger BioSciences

Tiger BioSciences, headquartered in Conshohocken, PA, is a leader in regenerative medicine, specializing in the repair and regeneration of human tissue compromised by disease, trauma, injury, and aging, with the goal of restoring natural function. Tiger is a vertically integrated tissue engineering company specializing in the recovery, processing, development, research, and distribution of cellular, acellular, and matrix-like products (CAMPs) and aesthetic technologies. Built on a deep heritage of human cell and tissue processing expertise, the company functions as a tissue recovery agency, processing innovator, aesthetics device manufacturer, and commercial partner to clinicians, delivering cutting-edge solutions that meet the evolving needs of providers and their patients and enabling life-changing, head-to-toe treatment options across a wide range of applications. Tiger BioSciences remains steadfast in its commitment to patients, providers, and donor families.